This topic contains a solution. Click here to go to the answer

Author Question: A Water Enterprise Fund (EF) issues 4 million of 5 revenue bonds on October 1, 2013 . The EF will ... (Read 31 times)

jerry coleman

  • Hero Member
  • *****
  • Posts: 570
A Water Enterprise Fund (EF) issues 4 million of 5 revenue bonds on October 1, 2013 . The EF will make its first payment of interest on March 31, 2014, together with a principal payment of 200,000 .
 
  What amount, if any, should the EF report in its fund statement of revenues, expenses, and changes in net position for the year ended December 31, 2013?
   a. zero
   b. interest expense of 100,000
   c. interest expense of 50,000 and principal expense of 100,000
   d. interest expense of 50,000

Question 2

Computerized accounting systems prevent all journalizing errors.
 a. True
  b. False
 
   Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

randomguy133

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

d

Answer to Question 2

False




jerry coleman

  • Member
  • Posts: 570
Reply 2 on: Jul 5, 2018
Thanks for the timely response, appreciate it


irishcancer18

  • Member
  • Posts: 310
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library